DEVELOPING — SINGLE SOURCE, NOT YET CORROBORATED
Rising US scrutiny on clinical trials could threaten China’s biotech advantage: analysts
🚨 US LAWMAKERS RAISE ALARM OVER DRUG TRIALS IN CHINA US lawmakers and Food and Drug Administration officials have raised the alarm about American pharmaceutical companies’ growing reliance on early clinical trials in China. Source: South China Morning Post #China